Speciality Medicines Ltd. Press Release May 21 2026

Speciality Medicines Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/05/2026 ,inter alia, to consider and approve 1. Audited Standalone Financial Statements of the company for the financial year ended on March 31, 2026. 2. To consider, approve and take on record Audited Standalone Financial Results of the company for the half year and the financial Year ended on March 31, 2026 as per Regulation 33 of Listing Regulations.3. Any other matter with the permission of the Chairman.

View Attachment